INTELLIPHARMACEUTICS INTERNATIONAL INC. — Revenue by Fiscal Year
14 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/e08c406d-c3b4-415c-bb35-4133bab5c132/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2022 | $65.7k | 2021-12-01 – 2022-11-30 | evidence 0001654954-23-008028 |
| FY 2021 | $0 | 2020-12-01 – 2021-11-30 | evidence 0001654954-22-002240 |
| FY 2020 | $1.4M | 2019-12-01 – 2020-11-30 | evidence 0001654954-21-002166 |
| FY 2019 | $3.5M | 2018-12-01 – 2019-11-30 | evidence 0001654954-20-002078 |
| FY 2018 | $1.7M | 2017-12-01 – 2018-11-30 | evidence 0001654954-20-002078 |
| FY 2017 | $5.5M | 2016-12-01 – 2017-11-30 | evidence 0001654954-20-002078 |
| FY 2016 | — | 2015-12-01 – 2016-11-30 | evidence 0001654954-17-000913 |
| FY 2015 | — | 2014-12-01 – 2015-11-30 | evidence 0001654954-17-000913 |
| FY 2014 | — | 2013-12-01 – 2014-11-30 | evidence 0001654954-17-000913 |
| FY 2013 | $1.5M | 2012-12-01 – 2013-11-30 | evidence 0001171843-14-000785 |
| FY 2012 | $107.1k | 2011-12-01 – 2012-11-30 | evidence 0001171843-13-000369 |
| FY 2011 | $501.8k | 2010-12-01 – 2011-11-30 | evidence 0001171843-12-001847 |
| FY 2010 | $1.5M | 2009-12-01 – 2010-11-30 | evidence 0001171843-12-001847 |
| FY 2009 | $630.2k | 2009-01-01 – 2009-11-30 | evidence 0001171843-12-001847 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
INTELLIPHARMACEUTICS INTERNATIONAL INC. — all facts · Net Income · Operating Income